Psychedelics and Youth
The discussion highlights the significant neuroplasticity in young brains and the potential risks associated with psychedelic use in adolescents. While there is currently limited formal research, the FDA is showing interest in studying these substances for therapeutic purposes in younger populations, particularly in relation to mental health issues like depression. The conversation also touches on the importance of understanding age as a factor in drug efficacy and safety.In this clip
From this podcast
Huberman Lab
Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38
Related Questions
How does brain plasticity change with age, as discussed in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Psychedelics and Youth?
What does Andrew Huberman say about psychedelic use when the brain is developing in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Psychedelics and Youth?
How does age affect neuroplasticity?